The Justice Department has taken a significant step in U.S. drug policy by proposing to reclassify marijuana as a less dangerous drug. This move acknowledges the medical benefits of cannabis and recognizes its lower potential for abuse compared to some of the most dangerous drugs in the nation.
The proposed rule, approved by Attorney General Merrick Garland, does not legalize marijuana for recreational use but seeks to move it from its current classification as a Schedule I drug to a Schedule III substance. This reclassification would place marijuana alongside substances like ketamine and some anabolic steroids.
The decision follows a recommendation from the federal Health and Human Services Department, prompted by President Joe Biden's call for a review of marijuana's status. Biden has also taken steps to pardon individuals convicted of simple possession of marijuana and urged governors and local leaders to do the same to address past injustices.
The announcement, coming in an election year, could help Biden garner support, especially among younger voters who have increasingly supported marijuana decriminalization. The proposed rule initiates a 60-day comment period, followed by a potential review by an administrative judge.
While some lawmakers and advocacy groups welcome the reclassification as a positive step, others argue that it does not go far enough and advocate for full legalization of marijuana. The U.S. Cannabis Council views the move as a significant shift away from past failed policies.
Despite differing opinions, the Justice Department emphasized that available data supports the reclassification of marijuana to Schedule III, aligning its abuse potential with other substances in that category. However, critics, including some medical professionals, caution against the change, citing insufficient scientific evidence.
Although the immediate impact on the criminal justice system is expected to be limited, easing federal regulations on marijuana could have broader implications for the industry and research. With many states already legalizing medical and recreational marijuana, federal policy is catching up to reflect changing attitudes and practices surrounding the drug.
Overall, the proposed reclassification of marijuana marks a significant shift in U.S. drug policy and sets the stage for further discussions on the regulation and legalization of cannabis.
